Literature DB >> 19935208

Will etravirine work in patients failing nonnucleoside reverse transcriptase inhibitor-based treatment in southern Africa?

Wendy S Stevens, Carole L Wallis, Ian Sanne, Francois Venter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19935208     DOI： 10.1097/QAI.0b013e3181ba1b00

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  6 in total

Review 1.  Antiretroviral therapy for children in resource-limited settings: current regimens and the role of newer agents.

Authors:  Brian S Eley; Tammy Meyers
Journal:  Paediatr Drugs       Date:  2011-10-01       Impact factor: 3.022

2.  Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.

Authors:  Anne Derache; Carole L Wallis; Saran Vardhanabhuti; John Bartlett; Nagalingeswaran Kumarasamy; David Katzenstein
Journal:  J Infect Dis       Date:  2015-07-14       Impact factor: 5.226

3.  Drug susceptibility and resistance mutations after first-line failure in resource limited settings.

Authors:  Carole L Wallis; Evgenia Aga; Heather Ribaudo; Shanmugam Saravanan; Michael Norton; Wendy Stevens; Nagalingeswaran Kumarasamy; John Bartlett; David Katzenstein
Journal:  Clin Infect Dis       Date:  2014-05-01       Impact factor: 9.079

4.  Low-abundance resistant mutations in HIV-1 subtype C antiretroviral therapy-naive individuals as revealed by pyrosequencing.

Authors:  Sandra Gonzalez; Damien C Tully; Clement Gondwe; Charles Wood
Journal:  Curr HIV Res       Date:  2013-01       Impact factor: 1.581

5.  Adult antiretroviral therapy guidelines 2017.

Authors:  Graeme Meintjes; Michelle A Moorhouse; Sergio Carmona; Natasha Davies; Sipho Dlamini; Cloete van Vuuren; Thandekile Manzini; Moeketsi Mathe; Yunus Moosa; Jennifer Nash; Jeremy Nel; Yoliswa Pakade; Joana Woods; Gert Van Zyl; Francesca Conradie; Francois Venter
Journal:  South Afr J HIV Med       Date:  2017-07-15       Impact factor: 2.744

6.  Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure.

Authors:  Marta Iglis Oliveira; Valter Romão de Souza Junior; Claudia Fernanda de Lacerda Vidal; Paulo Sérgio Ramos de Araújo
Journal:  BMC Infect Dis       Date:  2018-10-12       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.